A new national survey shows that, despite intense marketing, most Americans do not want the new weight-loss injectables, such ...

The COVID-19 pandemic made the world realize the importance of investing in healthcare infrastructure and developing treatments for unmet ...

Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, both of whom expressed interest in supporting the activist investor's ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...

The plaintiffs allege that the shortage of Lilly’s drugs isn’t actually over, and that the agency’s decision deprives ...

FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.